Solid Carcinoma clinical trials at University of California Health

3 in progress, 1 open to eligible people

Showing trials for

  • CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

    open to eligible people ages 18 years and up

    This is an open-label, dose-escalation, multi-center phase I study evaluating the safety of CF33-hNIS (hNIS - human sodium iodide symporter) administered via two routes of administration, intratumoral (IT) or intravenous (IV), either as a…

    at UCSD

  • Imaging of Solid Tumors Using 18F-TRX

    Sorry, not yet accepting patients

    This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile…

    at UCSF

  • PET [89Zr]DFO-starPEG in Solid Tumors

    Sorry, not yet accepting patients

    This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and …

    at UCSF

Our lead scientists for Solid Carcinoma research studies include .

Last updated: